Figure 7.
Scutellarin reverses cisplatin resistance in glioma cells through regulating the ERK/p53/caspase-3 and PI3K/Akt/mTOR pathways.
Scutellarin reverses cisplatin resistance in glioma cells through regulating the ERK/p53/caspase-3 and PI3K/Akt/mTOR pathways.